MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
- Medtronic Plc (NYSE:MDT) is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology stents due to a risk of the devices' wires and tubes fracturing and breaking off.
- The devices are used for brain aneurysms that bulge or balloon out the sides of the blood vessel (wide-neck and fusiform).
- The Pipeline Flex Devices include a guidewire-based delivery system used to place the implant inside the patient.
- The FDA says that fractured pieces could be left inside the patient's brain bloodstream.
- The agency also noted that the attempts to retrieve the fractured pieces might worsen the patient's condition.
- The fragments can also cause other serious adverse health consequences such as continued blockage of blood vessels, stroke, and death.
- So far, the FDA says there have been 59 device malfunctions reported, ten serious injuries, and two deaths related to the products.
- The agency had classified the recall as Class I, the most serious type of recall.
- Related content: Benzinga's Full FDA Calendar.
- Price Action: MDT stock is down 1.56% at $127.69 during the market session on the last check Monday.
MEMORIAL DAY FLASH SALE: 50% OFF BENZINGA PRO
As we honor our freedom, take a stand today. Secure the financial freedom that both you and your family deserve. Get exclusive market moving news for just 50% off. Claim your 50% discount here.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!